Home  /  Resource Library  /  Real-world outcomes of bispecific antibodies in relapsed/refractory (R/R) follicular lymphoma (FL)

Real-world outcomes of bispecific antibodies in relapsed/refractory (R/R) follicular lymphoma (FL)

ASCO 2026